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Ryanodine receptor type 2 (RyR2) mutations are implicated in catecholaminergic
polymorphic ventricular tachycardia (CPVT) thought to result from altered myocyte Ca2+
homeostasis reflecting inappropriate “leakiness” of RyR2-Ca2+ release channels arising
from increases in their basal activity, alterations in their phosphorylation, or defective
interactions with other molecules or ions. The latter include calstabin, calsequestrin-2,
Mg2+, and extraluminal or intraluminal Ca2+. Recent clinical studies additionally
associate RyR2 abnormalities with atrial arrhythmias including atrial tachycardia (AT),
fibrillation (AF), and standstill, and sinus node dysfunction (SND). Some RyR2 mutations
associated with CPVT in mouse models also show such arrhythmias that similarly
correlate with altered Ca2+ homeostasis. Some examples show evidence for increased
Ca2+/calmodulin-dependent protein kinase II (CaMKII) phosphorylation of RyR2. A
homozygotic RyR2-P2328S variant demonstrates potential arrhythmic substrate resulting
from reduced conduction velocity (CV) in addition to delayed afterdepolarizations (DADs)
and ectopic action potential (AP) firing. Finally, one model with an increased RyR2
activity in the sino-atrial node (SAN) shows decreased automaticity in the presence
of Ca2+-dependent decreases in ICa, L and diastolic sarcoplasmic reticular (SR) Ca2+
depletion.
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INTRODUCTION
Catecholaminergic polymorphic ventricular tachycardia (CPVT)
is one of the most malignant cardiac channelopathies. It is char-
acterized by episodic, life-threatening, arrhythmias provoked by
stress and emotion in individuals with otherwise structurally
normal hearts (Swan et al., 1999; Priori et al., 2001; Priori and
Chen, 2011). Two genes have been implicated in CPVT. One,
transmitted as an autosomal dominant trait, is caused by muta-
tions in the ryanodine receptor type 2 (RyR2) gene (Laitinen
et al., 2001; Priori et al., 2001). It accounts for 50–55% of the
CPVT cases attributable to genetic abnormalities (Priori et al.,
2002). The other, less common, recessive variant results from
mutations in the cardiac-specific isoform of calsequestrin type
2 gene (CASQ2) (Lahat et al., 2001). There are currently more
than 150 known pathological allelic variants involving RyR2 that
are associated with CPVT (Priori and Chen, 2011). Ventricular
arrhythmia has been attributed in such cases to altered myocyte
Ca2+ homeostasis. This results in an inappropriate “leakiness”
of RyR2-Ca2+ release channels owing to increases in their basal
activity, altered phosphorylation status or defective interactions
with other molecules or ions, including calstabin (FKBP12.6)
(Lehnart et al., 2004b), CASQ2, or Mg2+, or abnormal activation
by extra- or intraluminal Ca2+ (Wehrens et al., 2004). This in
turn results in spontaneous Ca2+ waves of Ca2+-induced Ca2+
release (CICR) in turn producing the delayed afterdepolarisation
(DADs) thought to be the major cause of RyR2-associated CPVT
(George et al., 2007; Mohamed et al., 2007; Priori and Chen,
2011). Seven RyR2 mutations are additionally associated with
atrial arrhythmic disorders that include atrial tachycardia (AT),
fibrillation (AF), and standstill as well as sinus node dysfunction
(SND) (Laitinen et al., 2001; Bhuiyan et al., 2007; Sumitomo et al.,
2007; Beery et al., 2009; Marjamaa et al., 2009; Kazemian et al.,
2011). RyR mutations can thus affect function in cardiac regions
including sino-atrial node (SAN), atria, and atrioventricular (AV)
node in addition to ventricular myocardium. This review sur-
veys atrial arrhythmias and SNDs related to RyR2 mutations as
revealed by investigations in genetically modified murine cardiac
models.
FEATURES OF Ca2+ HOMEOSTASIS IN SINO-ATRIAL AND
ATRIAL CELLS HAVE IMPLICATIONS FOR RHYTHM
ABNORMALITIES
Atrial myocytes show differences from ventricular cells in their
Ca2+ homeostasis in some important respects, with implications
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for the physiological consequences of alterations in their RyR2
function. Thus, atrial myocytes of small mammals lack exten-
sive T-tubules (Mackenzie et al., 2001, 2004; Brette and Orchard,
2003). These are replaced by prominent, transversely-orientated,
sarcoplasmic reticular (SR), Z-tubular, elements. Junctional
RyR2–L-type Ca2+ channel (LTCC) clusters are confined to the
cell peripheries in contrast to their dense distribution through-
out the more extensive ventricular tubular system (Mackenzie
et al., 2001). However, an abundant corbular SR contains non-
junctional RyR2s (Jorgensen et al., 1993). Atrial activation is thus
likely initiated by CICR following voltage-sensitive extracellu-
lar Ca2+ entry at the peripheral T-SR junctional elements. This
initiates a centripetal propagation of this CICR process thereby
increasing open probabilities in the corbular RyR2-Ca2+ release
channels in the cell interior (Bootman et al., 2001; Mackenzie
et al., 2001, 2004; Blatter et al., 2003; Sheehan and Blatter, 2003).
The detailed mechanisms leading to AF are poorly understood.
Nevertheless, increasing evidence implicates alterations in intra-
cellular Ca2+ signaling in its associated focal firing, substrate
evolution and remodeling processes (Hove-Madsen et al., 2004;
Vest et al., 2005; Dobrev and Nattel, 2008; Liang et al., 2008;
Qi et al., 2008; Chelu et al., 2009; Dobrev, 2010). Acute atrial
arrhythmogenesis in intact hearts in turn is related to diastolic
Ca2+ events in atrial myocytes. These depend upon finite SRCa2+
stores and diastolic CICR processes both of which ultimately
depend upon extracellular Ca2+ entry. Thus, ectopic activity
results from afterdepolarisation and triggered activity, whether
arising from increased action potential duration (APD) resulting
in early afterdepolarisation (EAD) or SR Ca2+ release resulting
in DAD phenomena, and may trigger re-entrant activity or drive
atrial rhythm at rapid rate resulting in fibrillatory conduction.
However, reentry requires a vulnerable substrate, likely deter-
mined by the balance of conduction velocity (CV) and refractory
period (Comtois et al., 2005; Dobrev and Nattel, 2008; Nattel
et al., 2008).
Atrial myocytes from chronic AF patients similarly show
increased frequencies of pro-arrhythmic spontaneous Ca2+
release events (Hove-Madsen et al., 2004; Vest et al., 2005). These
took place despite reduced L-type voltage-dependent Ca2+ cur-
rents (Bosch et al., 1999; Van Wagoner et al., 1999; Workman
et al., 2001; Christ et al., 2004) and have accordingly been
attributed to increased RyR2-mediated Ca2+ release activity (De
Bakker et al., 2002; Vest et al., 2005). Thus, RyR2-single-channel
open probabilities were increased in canine hearts with persis-
tent AF. AF is also associated with increased protein kinase A
(PKA)-mediated RyR2 phosphorylation at S2808 and decreased
calstabin binding to RyR2 (Vest et al., 2005). Such changes would
be expected to cause a failure of RyR2 channel closure resulting
in a potentially arrhythmogenic Ca2+ leak from the SR (Wehrens
et al., 2004; Balasubramaniam et al., 2005; Chelu and Wehrens,
2007). However, the extent to which such a mechanism might
be directly applicable to AF remains under discussion (Venetucci
et al., 2007; Eckstein et al., 2008).
These general principles are likely to be applicable to atria in
murine hearts, which have previously also provided useful models
for studies of ventricular arrhythmic phenomena. Introduction
of caffeine transiently induced diastolic Ca2+ waves in regularly
stimulated atrial myocytes. This could result either from RyR2
sensitization to cytosolic Ca2+ or increased intracellular cAMP
levels resulting from phosphodiesterase inhibition (Daly, 2007).
However, this effect was inhibited by prior inhibition of either
Ca2+-ATPase activity by cyclopiazonic acid or of extracellular
Ca2+ entry by nifedipine. These latter findings in turn directly
correlated with the induction of atrial arrhythmic tendency or its
inhibition by the same agents in intact hearts (Zhang et al., 2009,
2011).
Possible roles for RyR2-Ca2+ release channels in normal
SAN pacemaker activity remain under discussion (Mangoni and
Nargeot, 2008; Lakatta and Difrancesco, 2009). The SAN contains
both RyR2 and RyR3 as well as SR Ca2+ stores (Masumiya et al.,
2003). Release of intracellularly stored Ca2+ tends to activate
depolarizing inward Na+/Ca2+ exchange current (Rubenstein
and Lipsius, 1989; Ju and Allen, 1998; Terrar and Rigg, 2000;
Bogdanov et al., 2001; Lakatta et al., 2010). Should this occur at
the end of diastolic depolarization it could potentially facilitate
action potential (AP) firing. Such findings have given rise to sug-
gestions for a “Ca2+ clock” (Bogdanov et al., 2001; Vinogradova
et al., 2004). Certainly, SAN cells show high basal levels of cAMP
that could increase PKA-dependent RyR2 phosphorylation mod-
ulating its release of Ca2+ and thereby potentially influencing
SAN pacemaker function (Vinogradova et al., 2006). Ryanodine-
mediated RyR2 block indeed reduces SAN beating frequency
(Rubenstein and Lipsius, 1989; Ju and Allen, 1998; Bogdanov
et al., 2001). However, others have suggested that such SR Ca2+
release is not a predominant factor in normal SAN pacemaker
activity (Honjo et al., 2003; Mangoni and Nargeot, 2008; Lakatta
and Difrancesco, 2009; Himeno et al., 2011).
RyR2 MUTATIONS ARE ASSOCIATEDWITH CLINICAL ATRIAL
ARRHYTHMIC AND SND PHENOTYPES
A number of RyR2mutations associated with CPVT are also asso-
ciated with atrial arrhythmias and SND (Table 1). However, there
have been no reported cases of lone AF or SAN dysfunction in the
absence of CPVT. Large deletions encompassing exon 3 in RyR2
NH2-terminal regions are relatively frequent. This may reflecting
their containing Alu repeats predisposing to deletions resulting
from large Alu repeat–mediated genomic rearrangements result-
ing from polymerase slippage (Gu et al., 2008). Alu sequences
occur in intron 2, 190 bp upstream from exon 3 and also 536 bp
downstream in intron 3. They are related to the 1.1 kb dele-
tion containing part of intron 2, exon 3, and part of intron 3,
with a Alu-Alu recombination in which exon 2 is recombined
with exon 4 and exon 3 is completely deleted (Bhuiyan et al.,
2007; Marjamaa et al., 2009; Medeiros-Domingo et al., 2009).
However, crystal structure studies revealed that exon 3 deletion
causes a structural rescue whereby a flexible loop inserts itself
into the β trefoil domain. This increases the thermal stability
of the RyR2 channel. As a result the mutation is neither lethal
nor confers loss of function (Lobo et al., 2011). In the HEK293
expression system, it results in a marked reduction in the lumi-
nal Ca2+ threshold at which Ca2+ release terminates thereby
increasing fractional Ca2+ release (Tang et al., 2012). The RyR2
NH2-terminal region may thus be an important determinant for
termination of Ca2+ release, abnormalities in which are common
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Table 1 | Summary of RyR2 mutations associated with atrial and/or sinoatrial node dysfunction.
Nucleotide Amino acid
change
Mutation Location Exon Phenotype References
1.1 kb deletion Exon 3
deletion
Deletion Amino terminal
domain
3 CPVT, SND, AV nodal block, AF, and
atrial standstill, DCM
Bhuiyan et al., 2007;
Marjamaa et al., 2009;
Medeiros-Domingo et al.,
2009
C6982T P2328S Missense FKBP binding
domain
46 CPVT, AT, Normal heart structure Laitinen et al., 2001
-No information G3946A Missense Cytosol 88 CPVT, AT, AF, Normal heart structure Pizzale et al., 2008
T12056G M4109R Missense Domain II 90 CPVT, AF, transient QT prolongation
during AF, and postpacing, Normal
heart structure
Nof et al., 2011
A12457C S4153R Missense Domain II 90 CPVT, AF, Normal heart structure Kazemian et al., 2011
-No information W4645R Missense Transmembrane
domain
96 CPVT, AF, Normal heart structure Beery et al., 2009
-No information A7420G Missense C-Terminal
domain
105 CPVT, AF, Normal heart structure Sumitomo et al., 2007
in RyR2-associated cardiomyopathies (Gu et al., 2008; Tang et al.,
2012).
A large exon 3 deletion has been reported in a number of unre-
lated families. It has been associated with a broad range of atrial,
ventricular and SND phenotypes. Thus, several unrelated fami-
lies showed a large deletion encompassing part of intron 2, exon
3, and part of intron 3, expected to result in an in-frame dele-
tion of 35 amino acids (p.Asn57-Gly91) (NM-001035) (Bhuiyan
et al., 2007; Marjamaa et al., 2009; Medeiros-Domingo et al.,
2009). This deletion was associated with a spectrum of pheno-
types including SND, AF, atrioventricular block (AVB), decreased
left ventricular function, increased trabeculation, CPVT, and
dilated cardiomyopathy (DCM). Two further families showing
CPVT with large deletions in the region did not show the asso-
ciation with DCM (Marjamaa et al., 2009). Mutation carriers in
one of these families showed CPVT, AF, sinus bradycardia, and
AV conduction abnormalities without structural cardiovascular
abnormalities. Patients from the other family showed increased
left ventricular trabeculation suggestive of non-compaction car-
diomyopathy (Marjamaa et al., 2009). An additional report of
a large large 3.6 Kb exon 3 deletion was not accompanied by a
description of the corresponding patient phenotype (Medeiros-
Domingo et al., 2009).
Some single CPVT-associated RyR2 mutations are also asso-
ciated with atrial arrhythmias. Two such families, including one
with RyR-P2328S, contained 14 CPVT patients (Swan et al., 1999;
Laitinen et al., 2001). All carriers showed polymorphic ventricular
tachycardia (PVT) and/or ventricular fibrillation (VF) of which
three patients also showed non-sustained AT. Three further case
reports described a further three RyR2 mutations all of which
showed AT and/or AF in addition to CPVTwithout abnormalities
in cardiac structure (Sumitomo et al., 2007; Pizzale et al., 2008;
Kazemian et al., 2011). Thus, a patient with the RyR2-G3946A
variant who had an implantable cardioverter defibrillator (ICD)
for CPVT showed AT/AF both during exercise and on ambula-
tory electrocardiographic (ECG) recording (Pizzale et al., 2008).
The RyR2-S4153R variant was identified in a women present-
ing with a cardiac arrest due to VF; she showed AF on 12-lead
ECG immediately following emergency defibrillation. Over a 12
month follow-up period, in addition to experiencing three ICD
shocks related to appropriately detected PVTs, she showed sev-
eral exercise-induced self-terminating episodes of AF with rapid
ventricular responses (Kazemian et al., 2011). Finally, a RyR2-
A7420G variant was identified in a patient with both clinical and
induced AF as well as frequent episodes of paroxysmal AF during
walking or with mental stress despite normal sinus node recovery
times (SNRT) and cardiac structure (Sumitomo et al., 2007).
In a further clinical situation, a preceding rapid AF could
initiate CPVT, after a marked transient QT prolongation fol-
lowing a long RR interval that in turn followed a sequence
of short R-R beats. This was associated with two heterozygous
nucleotide substitutions, RyR2-M4109R and RyR2-I406T. All the
RyR2-M4109R but none of the RyR2-I606T carriers showed
prominent postpacing QT prolongation during electrophysiolog-
ical study, although both showed normal QT intervals during
regular rhythm (Nof et al., 2011). Finally, VT and AT could
be induced by isoproterenol infusion, an effect blocked by pro-
pranolol administration, in a mother and son both having a
RyR2-W4645R mutation and clinical diagnoses of PVT and AT
in an absence of detectable significant underlying cardiac disease
(Beery et al., 2009).
ATRIAL ARRHYTHMIC AND Ca2+ HOMEOSTATIC
ABNORMALITIES IN MOUSE MODELS HARBORING RyR2
MUTATIONS
Increased diastolic Ca2+ release has been implicated in generation
of ventricular arrhythmias in genetically modified mouse models
harboring CPVT-related RyR2 mutations (Cerrone et al., 2005;
Kannankeril et al., 2006; Goddard et al., 2008; Lehnart et al., 2008;
Suetomi et al., 2011). Recently, a fewmouse models have similarly
shown atrial arrhythmias and SND and similarly demonstrated
evidence for diastolic SR Ca2+ release through “leaky” RyR2s
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(Chelu et al., 2009; Suetomi et al., 2011; Zhang et al., 2011; Neco
et al., 2012; Shan et al., 2012).
RyR2-R176Q/+ mice (Kannankeril et al., 2006) did not show
spontaneous AF but nevertheless showed increased vulnerabili-
ties to AF during rapid atrial pacing when compared to wild-type
(WT). This was associated with increased Ca2+/calmodulin-
dependent protein kinase II (CaMKII) phosphorylation of RyR2.
Conversely, pharmacological inhibition of CaMKII prevented this
AF inducibility. So did genetic inhibition of CaMKII-mediated
RyR2 phosphorylation in RyR2-S2814A mice studied in a vago-
tonic AFmodel. Atrial biopsies frommice with atrial enlargement
and spontaneous AF, goats with lone AF, and patients with
chronic AF similarly showed increased CaMKII phosphorylation
of RyR2. These findings implicate a RyR2-dependent Ca2+ release
resulting from increased CaMKII activity in susceptibility to AF
(Chelu et al., 2009).
The RyR2-P2328S mutation has been clinically related to
atrial in addition to ventricular arrhythmic phenotypes (Swan
et al., 1999; Laitinen et al., 2001). Heterozygotic and homozy-
gotic RyR2-P2328S mouse atria both showed acute arrhyth-
mogenic properties in the absence of structural abnormalities
with a severity related to gene dose, consistent with previous
results in expression systems (Lehnart et al., 2004a). Intact anaes-
thetized hetero- or homozygotic RyR2-P2328S showed normal
electrocardiographic parameters both before and after isopro-
terenol addition apart from increased heart rates. Nevertheless,
bipolar electrogram and monophasic AP recordings from either
regular or programmed stimulation demonstrated higher atrial
arrhythmogenic incidences in isolated perfused homozygotic but
not heterozygotic RyR2-P2328S relative to WT. Isoproterenol
increased these incidences in all three groups despite unchanged
AP durations at 90% recovery (APD90) and atrial effective refrac-
tory periods (AERP) (Figure 1A). These findings correlated with
occurrences of diastolic Ca2+ release phenomena in regularly
stimulated, isolated, fluo-3-loaded RyR2S/S, but not RyR2+/S or
WT, atrial myocytes, whose frequency was increased by isopro-
terenol (Figure 1B) (Zhang et al., 2011). Finally, microelectrode
recordings in isolated perfused homozygotic RyR2-P2328S atria
showed DADs and ectopic APs not found in WT that could
potentially result from such Ca2+ release phenomena (King et al.,
2013). These also further implicated atrial arrhythmic substrate
resulting from reduced CV in agreement with similar results bear-
ing on ventricular conduction (Zhang et al., 2013). This was
reflected in their increased interatrial conduction delays, reduced
FIGURE 1 | (A) Atrial monophasic action potential recording of arrhythmic
events provoked by programmed electrical stimulation involving extrasystolic
S2 stimulation (long vertical bars beneath trace) following series of pacing S1
stimuli (short vertical bars beneath trace) from isolated perfused homozygotic
RyR2-P2328S heart. (B) Ca2+ transients from regularly stimulated
fluo-3-loaded RyR2-P2328S atrial myocytes under confocal microscopy, both
following introduction of isoproterenol [From Figures 5D, 6F of Zhang et al.
(2011)].
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epicardial CVs and reduced maximum rates of AP depolariza-
tion [(dV/dt)max], despite similar effective refractory periods, AP
durations and AP amplitudes.
Finally, AF could be induced by an intra-esophageal burst
pacing protocol in mice harboring the RyR2-R2474S+/−, RyR2-
N2386I+/−, and RyR2-L433P+/− mutations known to be asso-
ciated with human CPVT. Their isolated atrial myocytes showed
significant diastolic SR Ca2+ leaks. Atrial RyR2s from RyR2-
R2474S+/− mice were oxidized and their RyR2 complexes
depleted of the calstabin2 unit known to stabilize the RyR2 closed
state. The Rycal agent S107, known to stabilize RyR2-calstabin2
interactions and inhibit the oxidation/phosphorylation-induced
dissociation of calstabin2 from the channel, rescued the resulting
increase in Ca2+ release, and prevented burst pacing–induced AF
in vivo. It did not do so in calstabin2-deficient mice, implicating
calstabin2 in these arrhythmic properties (Shan et al., 2012).
PARADOXICAL SINUS NODE DISORDER IN MOUSE MODELS
HARBORING RyR2 MUTATIONS
In contrast to experimental evidence implicating a Ca2+ clock
involving RyR2 in pacemaker activity (see section on Features
of Ca2+ homeostasis in sino-atrial and atrial cells have implica-
tions for rhythm abnormalities), CPVT is associated with high
incidences of SAN dysrhythmia in the form of reduced SAN
automaticity resulting in basal bradycardia, sinus pauses, and
impaired chronotropic responses to β-adrenergic stimulation
(Leenhardt et al., 1995; Sumitomo et al., 2003; Postma et al., 2005;
Katz et al., 2009). Although they do not show a basal bradycardia,
RyR2-R4496C mice studied using in vivo telemetric recordings
similarly showed sinus pauses overcome by atrial and junctional
escapes triggered by catecholamines, and impaired SAN auto-
maticity following isoproterenol injection. These features paral-
leled post-exercise findings in CPVT patients (Neco et al., 2012).
Measurements of spontaneous [Ca2+]i transients reflecting pace-
maker activity in SAN cells by confocal microscopy correspond-
ingly demonstrated slower pacemaker activity and impaired
chronotropic responses to β-adrenergic stimulation, and sinus
pauses in 75% of the cases. These changes were associated with
50% reductions in L-type Ca2+ current (ICa, L) density in whole-
cell patch-clamped RyR2-R4496C SAN cells. Isoproterenol dra-
matically increased the frequency of Ca2+ sparks and Ca2+ waves
by ∼5 and ∼10-fold (Neco et al., 2012).
CONCLUSION
Enhanced RyR2 activity associated with RyR2 mutations can be
associated with atrial arrhythmic tendency and SND. This is
potentially attributable to increased RyR2-mediated release of
intracellularly stored, SR, Ca2+ release and altered interactions
with CaMKII and calstabin2. Increased RyR2 activity in the SAN
leads to an unanticipated decrease in its automaticity accompa-
nied by a Ca2+-dependent decrease of ICa, L and diastolic SR Ca2+
depletion.
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